MDS has appointed Steve West, current president of MDS Nordion of Ottawa, to the position of COO of the Toronto-based parent company and also to lead the firm following a planned restructuring.
West will become MDS' next CEO, replacing Stephen DeFalco, the current president and CEO. DeFalco will step down from those positions when MDS completes two planned strategic transactions.
West has served as president of MDS Nordion since 2003. He began his career at MDS in 2001 as a senior partner with MDS Capital.
On September 2, MDS entered into an agreement to sell its MDS Analytical Technologies business to diversified conglomerate Danaher, based in Washington, DC, for $650 million ($611 million U.S.) in cash.
MDS also intends to sell its MDS Pharma Services business, which provides drug discovery and early-stage development products for pharmaceutical and biotechnology companies.
Related Reading
MDS to divest non-Nordion units, September 2, 2009
MDS offers plan to fix Maple reactors, July 31, 2009
MDS urges Canada to complete Maple project, July 9, 2009
MDS posts loss in Q2 results, June 11, 2009
MDS begins CardioGen-82 production, June 10, 2009
Copyright © 2009 AuntMinnie.com
